|Last Price$13.87||Day Change (%)0.43%|
|Open Price$13.70||Day Change ($)0.06|
|Day Range13.70–13.98||52-Week Range8.21–16.00|
As of Wed 12/04/2013 05:18 PM EST | USD
InterMune Announces Pricing of Public Offering of 6,500,000 Shares of Common Stock
Blockbuster sales and takeover potential create an attractive risk/reward tradeoff for this speculative biotech.
We see opportunity as fleeing investors trigger an irrational sell-off.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
Fancy names can't make up for bad businesses.